BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 30814458)

  • 41. Clonal dissemination of extensively drug-resistant Acinetobacter baumannii producing an OXA-23 β-lactamase at a teaching hospital in Shanghai, China.
    Li Y; Guo Q; Wang P; Zhu D; Ye X; Wu S; Wang M
    J Microbiol Immunol Infect; 2015 Feb; 48(1):101-8. PubMed ID: 24863499
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Emerging challenges of whole-genome-sequencing-powered epidemiological surveillance of globally distributed clonal groups of bacterial infections, giving Acinetobacter baumannii ST195 as an example.
    Jia H; Chen Y; Wang J; Xie X; Ruan Z
    Int J Med Microbiol; 2019 Nov; 309(7):151339. PubMed ID: 31451388
    [TBL] [Abstract][Full Text] [Related]  

  • 43. OXA-23 and ISAba1-OXA-66 class D β-lactamases in Acinetobacter baumannii isolates from companion animals.
    Ewers C; Klotz P; Leidner U; Stamm I; Prenger-Berninghoff E; Göttig S; Semmler T; Scheufen S
    Int J Antimicrob Agents; 2017 Jan; 49(1):37-44. PubMed ID: 27890443
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Investigation of a possible outbreak of carbapenem-resistant Acinetobacter baumannii in Odense, Denmark using PFGE, MLST and whole-genome-based SNPs.
    Hammerum AM; Hansen F; Skov MN; Stegger M; Andersen PS; Holm A; Jakobsen L; Justesen US
    J Antimicrob Chemother; 2015 Jul; 70(7):1965-8. PubMed ID: 25795772
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Characterisation of carbapenem-resistant Acinetobacter baumannii outbreak strains producing OXA-58 in Turkey.
    Kulah C; Mooij MJ; Comert F; Aktas E; Celebi G; Ozlu N; Rijnsburger MC; Savelkoul PH
    Int J Antimicrob Agents; 2010 Aug; 36(2):114-8. PubMed ID: 20510587
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Acinetobacter baumannii clonal lineages I and II harboring different carbapenem-hydrolyzing-β-lactamase genes are widespread among hospitalized burn patients in Tehran.
    Mahdian S; Sadeghifard N; Pakzad I; Ghanbari F; Soroush S; Azimi L; Rastegar-Lari A; Giannouli M; Taherikalani M
    J Infect Public Health; 2015; 8(6):533-42. PubMed ID: 26111484
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Identification of Acinetobacter species and genotyping of Acinetobacter baumannii by multilocus PCR and mass spectrometry.
    Ecker JA; Massire C; Hall TA; Ranken R; Pennella TT; Agasino Ivy C; Blyn LB; Hofstadler SA; Endy TP; Scott PT; Lindler L; Hamilton T; Gaddy C; Snow K; Pe M; Fishbain J; Craft D; Deye G; Riddell S; Milstrey E; Petruccelli B; Brisse S; Harpin V; Schink A; Ecker DJ; Sampath R; Eshoo MW
    J Clin Microbiol; 2006 Aug; 44(8):2921-32. PubMed ID: 16891513
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Wide spread of OXA-23-producing carbapenem-resistant Acinetobacter baumannii belonging to clonal complex II in different hospitals in Lebanon.
    Al Atrouni A; Hamze M; Jisr T; Lemarié C; Eveillard M; Joly-Guillou ML; Kempf M
    Int J Infect Dis; 2016 Nov; 52():29-36. PubMed ID: 27663910
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Outbreak of imipenem-resistant Acinetobacter calcoaceticus-Acinetobacter baumannii complex harboring different carbapenemase gene-associated genetic structures in an intensive care unit.
    Lee YT; Fung CP; Wang FD; Chen CP; Chen TL; Cho WL
    J Microbiol Immunol Infect; 2012 Feb; 45(1):43-51. PubMed ID: 22169123
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Emergence of carbapenem resistance in Acinetobacter baumannii in the Czech Republic is associated with the spread of multidrug-resistant strains of European clone II.
    Nemec A; Krízová L; Maixnerová M; Diancourt L; van der Reijden TJ; Brisse S; van den Broek P; Dijkshoorn L
    J Antimicrob Chemother; 2008 Sep; 62(3):484-9. PubMed ID: 18477708
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Nursing Home as a Reservoir of Carbapenem-Resistant Acinetobacter baumannii.
    Bedenić B; Beader N; Godič-Torkar K; Vranić-Ladavac M; Luxner J; Veir Z; Grisold AJ; Zarfel G
    Microb Drug Resist; 2015 Jun; 21(3):270-8. PubMed ID: 25599131
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Genetic characterisation of carbapenem-resistant Gram-negative bacteria isolated from the University Hospital Mohamed Boudiaf in Ouargla, southern Algeria.
    Yagoubat M; Ould El-Hadj-Khelil A; Malki A; Bakour S; Touati A; Rolain JM
    J Glob Antimicrob Resist; 2017 Mar; 8():55-59. PubMed ID: 28007519
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Molecular epidemiology of Acinetobacter baumannii bloodstream isolates obtained in the United States from 1995 to 2004 using rep-PCR and multilocus sequence typing.
    Higgins PG; Janssen K; Fresen MM; Wisplinghoff H; Seifert H
    J Clin Microbiol; 2012 Nov; 50(11):3493-500. PubMed ID: 22895032
    [TBL] [Abstract][Full Text] [Related]  

  • 54. First Detection of GES-5 Carbapenemase-Producing Acinetobacter baumannii Isolate.
    Al-Agamy MH; Jeannot K; El-Mahdy TS; Shibl AM; Kattan W; Plésiat P; Courvalin P
    Microb Drug Resist; 2017 Jul; 23(5):556-562. PubMed ID: 27854148
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Interspecies dissemination of a novel class 1 integron carrying blaIMP-19 among Acinetobacter species in Japan.
    Yamamoto M; Nagao M; Matsumura Y; Matsushima A; Ito Y; Takakura S; Ichiyama S
    J Antimicrob Chemother; 2011 Nov; 66(11):2480-3. PubMed ID: 21862476
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Nosocomial bloodstream infections due to Acinetobacter baumannii, Acinetobacter pittii and Acinetobacter nosocomialis in the United States.
    Wisplinghoff H; Paulus T; Lugenheim M; Stefanik D; Higgins PG; Edmond MB; Wenzel RP; Seifert H
    J Infect; 2012 Mar; 64(3):282-90. PubMed ID: 22209744
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Temporal evolution of carbapenem-resistant Acinetobacter baumannii in Curitiba, southern Brazil.
    Schimith Bier KE; Luiz SO; Scheffer MC; Gales AC; Paganini MC; Nascimento AJ; Carignano E; Dalla Costa LM
    Am J Infect Control; 2010 May; 38(4):308-14. PubMed ID: 20123152
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antimicrobial susceptibility patterns and distribution of blaOXA genes among Acinetobacter spp. Isolated from patients at Tehran hospitals.
    Feizabadi MM; Fathollahzadeh B; Taherikalani M; Rasoolinejad M; Sadeghifard N; Aligholi M; Soroush S; Mohammadi-Yegane S
    Jpn J Infect Dis; 2008 Jul; 61(4):274-8. PubMed ID: 18653968
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Identification of multidrug- and carbapenem-resistant Acinetobacter baumannii in Canada: results from CANWARD 2007.
    McCracken M; DeCorby M; Fuller J; Loo V; Hoban DJ; Zhanel GG; Mulvey MR
    J Antimicrob Chemother; 2009 Sep; 64(3):552-5. PubMed ID: 19578083
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Endemic and epidemic acinetobacter species in a university hospital: an 8-year survey.
    van den Broek PJ; van der Reijden TJ; van Strijen E; Helmig-Schurter AV; Bernards AT; Dijkshoorn L
    J Clin Microbiol; 2009 Nov; 47(11):3593-9. PubMed ID: 19794057
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.